Skip to content

Navitas Semiconductor

US · NVTS #2453 by market cap Listed 1970
11.30 -0.67 -5.60%
Live - 5344 symbols - heartbeat 290s ago · 2026-10-08 07:00
Pre-market 11.08 -1.95%
After-hours 11.41 +0.97%
Overnight 11.16 -1.24%
Market cap
2.95B
P/B
3.68
EPS
-0.57
Reader sentiment Are you bullish or bearish on NVTS?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Ownership Signal how this is computed

Accumulating
  • Total institutional ownership rose 2.4 percentage points.

Institutional ownership

Held by institutions
56.56% +2.35pp
Institutions
400
As of
2026/Q3 vs. prior period

Ownership vs. money flow

Diverging

Institutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Holder types

Mutual Fund34.25%
Hedge Fund8.00%
Private Company6.77%
Individual/Insider6.07%
Public Company3.76%
VC/PE Fund3.06%
Government Pension Fund0.36%
Family Office/Trust0.24%
Insurance Company0.11%
Other37.38%

Top holders as of 2026-06-30

BlackRock 6.22% · 16.24M sh
Ranbir Singh 5.72% · 14.94M sh
Jane Street Group, LLC 4.71% · 12.30M sh
Vanguard Capital Management, LLC 3.99% · 10.42M sh
D. E. Shaw & Co., L.P. 3.67% · 9.58M sh
Vanguard Portfolio Management, LLC 3.44% · 8.98M sh
State Street Global Advisors 3.15% · 8.21M sh
Capricorn Investment Group LLC 3.06% · 7.99M sh
The Goldman Sachs Group, Inc. 1.97% · 5.16M sh
Geode Capital Management, LLC 1.93% · 5.04M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 19 buys · 31 sells

NameRoleStake
Ranbir Singh Executive Vice President of GeneSiC Business 5.72%
Eugene Sheridan Co-Founder, CEO, President & Chairman 0.14%
Todd Glickman Officer 0.07%
Dipender Saluja Independent Director 0.06%
Richard Hendrix Independent Director 0.05%
Cristiano Amoruso Independent Director 0.01%
David Moxam Independent Director 0.01%
Gary Wunderlich Independent Director 0.01%
Gregory Fischer Independent Director 0.00%
Davin D. Lee Independent Director 0.00%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-07-30 Dipender Saluja Independent Director Other Acquisition +1,815 $13.15–14.47
2026-07-30 Dipender Saluja Independent Director Other Acquisition +9,990 --
2026-07-21 Brian James Long Lead Independent Director Other Acquisition +9,990 --
2026-07-21 David Moxam Independent Director Other Acquisition +9,990 --
2026-07-21 Richard Hendrix Independent Director Other Acquisition +9,990 --
2026-07-21 Gary Wunderlich Independent Director Other Acquisition +9,990 --
2026-07-21 Davin D. Lee Independent Director Other Acquisition +9,990 --
2026-07-21 Cristiano Amoruso Independent Director Other Acquisition +9,990 --
2026-07-21 Gregory Fischer Independent Director Other Acquisition +9,990 --
2026-06-01 Gary Wunderlich Independent Director Other Disposition -6,280 --
2026-05-27 Richard Hendrix Independent Director Open Market Disposition -108,649 $29.34–29.66
2026-05-27 Richard Hendrix Independent Director Intent to Sell (Form 144) -75,000 $28.95
2026-05-27 Gary Wunderlich Independent Director Open Market Disposition -73,000 $28.11
2026-05-27 Live Oak Sponsor Partners, LLC -- Open Market Disposition -35,165 $28.14
2026-05-27 Live Oak Merchant Partners LLC -- Intent to Sell (Form 144) -35,165 $28.16
2026-05-27 Ranbir Singh Executive Vice President of GeneSiC Business Open Market Disposition -3,724,176 $28.72–29.29
2026-05-27 Ranbir Singh Executive Vice President of GeneSiC Business Intent to Sell (Form 144) -664,058 $28.72
2026-05-26 Richard Hendrix Independent Director Intent to Sell (Form 144) -33,649 $29.66
2026-05-26 Chris Allexandre Chief Executive Officer Open Market Disposition -13,323 $31.81
2026-05-26 Ranbir Singh Executive Vice President of GeneSiC Business Intent to Sell (Form 144) -3,060,118 $29.29

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-10-08 07:00:22 · For reference only, not investment advice and not tailored to your situation.